v3.25.1
Balance Sheet Components - Accrued and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Balance Sheet Components    
Accrued commercial and research and development manufacturing $ 6,823 $ 12,449
Accrued co-development costs and milestone payments   12,500
Royalty fee derivative liability (Notes 3 and 8) 26,228 13,620
Revenue participation liability, current (Note 8) 72 1,148
Accrued other 11,450 18,880
Lease liabilities, current 1,723 1,691
Total Accrued and other current liabilities $ 46,296 $ 60,288